207 related articles for article (PubMed ID: 28235486)
41. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin.
Zhang C; Zhu Q; Gu J; Chen S; Li Q; Ying L
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072916
[TBL] [Abstract][Full Text] [Related]
42. Expression of the monocarboxylate transporter 1 (MCT1) in cells of the porcine intestine.
Welter H; Claus R
Cell Biol Int; 2008 Jun; 32(6):638-45. PubMed ID: 18313333
[TBL] [Abstract][Full Text] [Related]
43. Targeting lactate production and efflux in prostate cancer.
Pereira-Nunes A; Simões-Sousa S; Pinheiro C; Miranda-Gonçalves V; Granja S; Baltazar F
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165894. PubMed ID: 32650130
[TBL] [Abstract][Full Text] [Related]
44. Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.
Khan A; Valli E; Lam H; Scott DA; Murray J; Hanssen KM; Eden G; Gamble LD; Pandher R; Flemming CL; Allan S; Osterman AL; Haber M; Norris MD; Fletcher JI; Yu DMT
Oncogene; 2020 Apr; 39(17):3555-3570. PubMed ID: 32123312
[TBL] [Abstract][Full Text] [Related]
45. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
46. [Effect of co-inhibition of MCT1 gene and NHE1 gene on proliferation and growth of human lung adenocarcinoma cells].
Zhang GZ; Huang GJ; Li WL; Wu GM; Qian GS
Ai Zheng; 2002 Jul; 21(7):719-23. PubMed ID: 12479094
[TBL] [Abstract][Full Text] [Related]
47. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
[TBL] [Abstract][Full Text] [Related]
48. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.
Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W
Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029
[TBL] [Abstract][Full Text] [Related]
49. Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway.
Wang B; Guan G; Zhao D
Biomed Pharmacother; 2020 May; 125():109961. PubMed ID: 32028241
[TBL] [Abstract][Full Text] [Related]
50. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
51. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.
Pinheiro C; Longatto-Filho A; Simões K; Jacob CE; Bresciani CJ; Zilberstein B; Cecconello I; Alves VA; Schmitt F; Baltazar F
Eur J Cancer; 2009 Sep; 45(13):2418-24. PubMed ID: 19628385
[TBL] [Abstract][Full Text] [Related]
52. Monocarboxylate Transporter 1 in Brain Diseases and Cancers.
Sun Y; Sun J; He Z; Wang G; Wang Y; Zhao D; Wang Z; Luo C; Tian C; Jiang Q
Curr Drug Metab; 2019; 20(11):855-866. PubMed ID: 31631816
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo.
Li R; Pan Y; He B; Xu Y; Gao T; Song G; Sun H; Deng Q; Wang S
Int J Oncol; 2013 Dec; 43(6):1885-94. PubMed ID: 24064772
[TBL] [Abstract][Full Text] [Related]
54. The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma.
Fang J; Quinones QJ; Holman TL; Morowitz MJ; Wang Q; Zhao H; Sivo F; Maris JM; Wahl ML
Mol Pharmacol; 2006 Dec; 70(6):2108-15. PubMed ID: 17000864
[TBL] [Abstract][Full Text] [Related]
55. Gastric cancer cells escape metabolic stress via the DLC3/MACC1 axis.
Lin L; Liu Y; Pan C; Zhang J; Zhao Y; Shao R; Huang Z; Su Y; Shi M; Bin J; Liao Y; Li N; Wang C; Liao W
Theranostics; 2019; 9(7):2100-2114. PubMed ID: 31037159
[TBL] [Abstract][Full Text] [Related]
56. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates.
Wang N; Jiang X; Zhang S; Zhu A; Yuan Y; Xu H; Lei J; Yan C
Cell; 2021 Jan; 184(2):370-383.e13. PubMed ID: 33333023
[TBL] [Abstract][Full Text] [Related]
57. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
[TBL] [Abstract][Full Text] [Related]
58. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy.
Lambert DW; Wood IS; Ellis A; Shirazi-Beechey SP
Br J Cancer; 2002 Apr; 86(8):1262-9. PubMed ID: 11953883
[TBL] [Abstract][Full Text] [Related]
59. Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk.
Miranda-Gonçalves V; Bezerra F; Costa-Almeida R; Freitas-Cunha M; Soares R; Martinho O; Reis RM; Pinheiro C; Baltazar F
Mol Carcinog; 2017 Dec; 56(12):2630-2642. PubMed ID: 28762551
[TBL] [Abstract][Full Text] [Related]
60. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
